Ovine Forestomach Matrix

临床试验

计划入组 30 人 · 首次发布于 2026 年 2 月 4 日

已完成

NCT04354012

Hidradenitis Suppurativa Wound Care

计划入组 5 人 · 首次发布于 2020 年 4 月 21 日

已完成

NCT00198458

Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

计划入组 65 人 · 首次发布于 2005 年 9 月 20 日

药物

查看全部 128 →

Biotech

Approved

Hyaluronidase (ovine)(Vitrase)

生产企业：Amphastar pharmaceutical inc, Primapharm inc，另有 2 家

相关疾病：Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma (DLBCL)，另有 5 项

Biotech

Approved

Corticorelin ovine triflutate(Acthrel)

相关疾病：Pituitary-dependent Cushing's syndrome

Biotech

Investigational

Matrix-M

机构

查看全部 51 →

Moerae Matrix, Inc.

United States

Matrix Biomed, Inc.

United States

3-D Matrix Ltd.

Japan

资讯

查看全部 432 →

去年

Endoform Natural Demonstrates Significant Healing Advantage for Venous Leg Ulcers in Large Real-World Study

去年

IDEAYA Biosciences Navigates Oncology Landscape with Precision Medicine Approach

去年

临床试验

Combined OFM and Vacuum-assisted Therapy for Expedited Regeneration Over Structures

Hidradenitis Suppurativa Wound Care

Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

药物

Hyaluronidase (ovine)(Vitrase)

Corticorelin ovine triflutate(Acthrel)

Matrix-M

机构

Moerae Matrix, Inc.

Matrix Biomed, Inc.

3-D Matrix Ltd.

资讯

Endoform Natural Demonstrates Significant Healing Advantage for Venous Leg Ulcers in Large Real-World Study

IDEAYA Biosciences Navigates Oncology Landscape with Precision Medicine Approach

IDEAYA Biosciences Navigates Oncology Landscape with Precision Medicine Approach